# Core outcome sets in symptomatic peripheral artery disease, COS-PAD: Study protocol for developing core outcome sets in symptomatic PAD utilising systematic reviews, interviews, and delphi consensus

**Authors:** Akam Shwan, Maria Gonzalez-Aguado, Rob D. Sayers, John S.M. Houghton, Biswabandhu Jana, Biswabandhu Jana, Biswabandhu Jana

PMC · DOI: 10.1371/journal.pone.0328453 · PLOS One · 2025-07-17

## TL;DR

This study aims to create standardized outcome measures for research on two types of peripheral artery disease to improve comparability and guide clinical practice.

## Contribution

The paper introduces a protocol to develop the first core outcome sets for intermittent claudication and CLTI in symptomatic PAD research.

## Key findings

- Two core outcome sets will be developed for intermittent claudication and CLTI using systematic reviews and stakeholder consensus.
- The study follows COMET guidelines and includes interviews and Delphi rounds to ensure stakeholder input.
- Ethical approval has been obtained to guide the development of best-practice standards for PAD research.

## Abstract

Symptomatic peripheral artery disease (PAD) presents as intermittent claudication or chronic limb-threatening ischaemia (CLTI). PAD research suffers from wide heterogeneity and non-comparability of outcome measures. The solution is to develop a core outcome set (COS) – a minimum standard of outcomes developed and agreed by key stakeholders (patients, healthcare professionals, and researchers). There are currently no agreed COSs for research in PAD. The aim of this project is to develop two separate COSs for symptomatic PAD; for each of intermittent claudication and CLTI.

The COSs will be developed according to Core Outcome Measures in Effectiveness Trials (COMET) guidelines. Two comprehensive systematic reviews will be supplemented by qualitative interviews of patients and carers and focus groups of healthcare professionals and researchers. A three-round Delphi consensus process followed by a stakeholder meeting will agree the final COSs. Full ethical approval has been granted by Health Research Authority, HRA and Health and Care Research Wales, HCRW (Brighton and Sussex REC reference 24/LO/0258).

Two separate core outcome sets for research involving patients with intermittent claudication and CLTI will be developed. This will aid study design and ensure meaningful results of clinical trials to guide patient management and development of best-practice guidelines for symptomatic PAD.

COMET registrations: 1590 and 2650

## Full-text entities

- **Diseases:** PAD (MESH:D058729), intermittent claudication (MESH:D007383), CLTI (MESH:D000089802)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12270175/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12270175/full.md

## References

23 references — full list in the complete paper: https://tomesphere.com/paper/PMC12270175/full.md

---
Source: https://tomesphere.com/paper/PMC12270175